Amgen to Undergo Experimental Treatment

Related Link: 

Amgen shareholders should be watching the development of U.S. biosimilars carefully.

Exxon's M&A Edge Over Chevron Amid Low Oil Prices

Related Link: 

Big Oil’s resiliency is strained amid low oil prices, but Exxon could yet capitalize via acquisitions.

Yahoo to Buy Social Shopping Site Polyvore

Related Link: 

Yahoo Inc. agreed to buy social shopping site Polyvore Inc., a move intended to enhance the portal’s “Mavens” growth strategy.

Japan Contraction Doesn't Mean More Easing

Related Link: 

Japan’s economy may turn out to have shrunk last quarter, but a new inflation measure gives the Bank of Japan an excuse not to act.

Fed's Bullard: 'In Good Shape' to Raise Rates in September

Related Link: 

Federal Reserve Bank of St. Louis President James Bullard says economic data seen since central bankers gathered this week are bolstering the case for raising short-term rates when officials meet in September.

An Unexpected Spike for Medicare Premiums?

Related Link: 

Some Medicare beneficiaries will face a steep increase in their 2016 premiums due to a little-noticed provision tied to Social Security unless the Department of Health and Human Services intervenes.

ECB Will Welcome Higher Core Inflation

Related Link: 

The ECB is watching closely for a turning point in eurozone inflation. July’s data mark a step closer.

Lloyds Can Bank on Green Light for Payouts

Related Link: 

U.K. regulators look set to give banks a looser rein than many thought—at least when it comes to returning cash to shareholders.

Consumers Priming U.S. Economic Pump

Related Link: 

Consumers are starting to spend more of the dividends they have received from lower gasoline prices.

Economy Picks Up but Stays in Its Rut

Related Link: 

The U.S. economy emerged from its winter lull with a moderate spring rebound, but the historically sluggish expansion is looking even more sluggish as it enters year seven.

Syndicate content